UniProt ID | PSA3_MOUSE | |
---|---|---|
UniProt AC | O70435 | |
Protein Name | Proteasome subunit alpha type-3 | |
Gene Name | Psma3 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 255 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). Binds to the C-terminus of CDKN1A and thereby mediates its degradation. Negatively regulates the membrane trafficking of the cell-surface thromboxane A2 receptor (TBXA2R) isoform 2.. | |
Protein Sequence | MSSIGTGYDLSASTFSPDGRVFQVEYAMKAVENSSTAIGIRCKDGVVFGVEKLVLSKLYEEGSNKRLFNVDRHVGMAVAGLLADARSLADIAREEASNFRSNFGYNIPLKHLADRVAMYVHAYTLYSAVRPFGCSFMLGSYSANDGAQLYMIDPSGVSYGYWGCAIGKARQAAKTEIEKLQMKEMTCRDVVKEVAKIIYIVHDEVKDKAFELELSWVGELTKGRHEIVPKDIREEAEKYAKESLKEEDESDDDNM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSSIGTGYD ------CCCCCCCCC | 30.57 | 26643407 | |
2 | Acetylation | ------MSSIGTGYD ------CCCCCCCCC | 30.57 | 16857966 | |
3 | Phosphorylation | -----MSSIGTGYDL -----CCCCCCCCCC | 24.60 | 26643407 | |
6 | Phosphorylation | --MSSIGTGYDLSAS --CCCCCCCCCCCCC | 30.79 | 26643407 | |
8 | Phosphorylation | MSSIGTGYDLSASTF CCCCCCCCCCCCCEE | 17.35 | 30635358 | |
11 | Phosphorylation | IGTGYDLSASTFSPD CCCCCCCCCCEECCC | 19.78 | 28066266 | |
13 | Phosphorylation | TGYDLSASTFSPDGR CCCCCCCCEECCCCC | 26.98 | 28066266 | |
14 | Phosphorylation | GYDLSASTFSPDGRV CCCCCCCEECCCCCE | 28.05 | 28066266 | |
16 | Phosphorylation | DLSASTFSPDGRVFQ CCCCCEECCCCCEEE | 23.36 | 26643407 | |
35 | Phosphorylation | MKAVENSSTAIGIRC HHHHHCCCCEEEEEE | 33.18 | 28464351 | |
52 | Acetylation | GVVFGVEKLVLSKLY CEEEEEEHHHHHHHH | 41.30 | 22826441 | |
57 | Malonylation | VEKLVLSKLYEEGSN EEHHHHHHHHHCCCC | 51.43 | 26320211 | |
57 | Ubiquitination | VEKLVLSKLYEEGSN EEHHHHHHHHHCCCC | 51.43 | - | |
57 | Acetylation | VEKLVLSKLYEEGSN EEHHHHHHHHHCCCC | 51.43 | 23806337 | |
65 | Succinylation | LYEEGSNKRLFNVDR HHHCCCCCCCCEECH | 52.77 | 23954790 | |
110 | Acetylation | FGYNIPLKHLADRVA CCCCCCHHHHHHHHH | 31.08 | 22826441 | |
110 | Ubiquitination | FGYNIPLKHLADRVA CCCCCCHHHHHHHHH | 31.08 | 22790023 | |
155 | Phosphorylation | QLYMIDPSGVSYGYW EEEEECCCCCCCCCH | 48.34 | - | |
158 | Phosphorylation | MIDPSGVSYGYWGCA EECCCCCCCCCHHHH | 19.16 | - | |
159 | Phosphorylation | IDPSGVSYGYWGCAI ECCCCCCCCCHHHHH | 16.30 | - | |
179 | Acetylation | AAKTEIEKLQMKEMT HHHHHHHHHHHHHCC | 50.08 | 22826441 | |
179 | Ubiquitination | AAKTEIEKLQMKEMT HHHHHHHHHHHHHCC | 50.08 | 22790023 | |
183 | Acetylation | EIEKLQMKEMTCRDV HHHHHHHHHCCHHHH | 31.22 | 22826441 | |
183 | Ubiquitination | EIEKLQMKEMTCRDV HHHHHHHHHCCHHHH | 31.22 | 22790023 | |
186 | Phosphorylation | KLQMKEMTCRDVVKE HHHHHHCCHHHHHHH | 12.89 | 18579562 | |
196 | Acetylation | DVVKEVAKIIYIVHD HHHHHHHHHHEEECH | 34.51 | 22826441 | |
206 | Malonylation | YIVHDEVKDKAFELE EEECHHHCCCCEEEE | 52.01 | 26320211 | |
206 | Acetylation | YIVHDEVKDKAFELE EEECHHHCCCCEEEE | 52.01 | 23236377 | |
206 | Ubiquitination | YIVHDEVKDKAFELE EEECHHHCCCCEEEE | 52.01 | - | |
222 | Ubiquitination | SWVGELTKGRHEIVP EECCHHHCCCCEECC | 67.58 | - | |
230 | Acetylation | GRHEIVPKDIREEAE CCCEECCHHHHHHHH | 55.69 | 22826441 | |
230 | Ubiquitination | GRHEIVPKDIREEAE CCCEECCHHHHHHHH | 55.69 | 22790023 | |
238 | Acetylation | DIREEAEKYAKESLK HHHHHHHHHHHHHHH | 58.52 | 22826441 | |
239 | Phosphorylation | IREEAEKYAKESLKE HHHHHHHHHHHHHHH | 17.89 | 25367039 | |
243 | Phosphorylation | AEKYAKESLKEEDES HHHHHHHHHHHCCCC | 43.99 | 22942356 | |
250 | Phosphorylation | SLKEEDESDDDNM-- HHHHCCCCCCCCC-- | 59.67 | 27087446 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PSA3_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PSA3_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PSA3_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of PSA3_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250, AND MASSSPECTROMETRY. | |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250, AND MASSSPECTROMETRY. | |
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis."; Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.; J. Proteome Res. 7:3957-3967(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250, AND MASSSPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243 AND SER-250, ANDMASS SPECTROMETRY. | |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250, AND MASSSPECTROMETRY. |